Kaiser Permanente Clinical Trials Tool Includes Cost-Effectiveness Modeling
Executive Summary
Kaiser Permanente is developing a clinical trials modeling tool that can also be used to estimate a drug's cost-effectiveness
You may also be interested in...
FDA Generic Biologics “Structure” To Come Soon; Policy Debate In 2005
FDA hopes to be in a position to kick off a legislative and policy debate on the feasibility of "follow-on" biologics by the beginning of 2005
FDA Generic Biologics “Structure” To Come Soon; Policy Debate In 2005
FDA hopes to be in a position to kick off a legislative and policy debate on the feasibility of "follow-on" biologics by the beginning of 2005
CMS Will Focus On Value, Not Price, Of Medicines, McClellan Pledges
Medicare reimbursement should be based on the "value" of medicines, not their price, incoming Centers for Medicare & Medicaid Services Administrator Mark McClellan told the Senate Finance Committee in a 1written Q&A exchange